Skip to main content
. Author manuscript; available in PMC: 2011 Aug 18.
Published in final edited form as: Clin Infect Dis. 2010 May 15;50(10):1387–1396. doi: 10.1086/652283

Figure 1.

Figure 1

Adjusted hazard ratios (HRs) and 95% confidence intervals of risk factors at start of antiretroviral therapy for specific causes of death from Cox models with CD4 cell count (per 100 cell decrease), transmission risk group (injection drug user [IDU] vs non-IDU), viral load (human immunodeficiency virus type 1 RNA load ≥5 vs <5 log copies/mL), and prior AIDS diagnosis (vs no AIDS). Models were mutually adjusted for age, sex, IDU, CD4 count, viral load, prior AIDS diagnosis, cohort, and year of starting antiretroviral therapy. CVD, cardiovascular disease.